These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 22292654)
1. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. Zhang G; Li M; Jin J; Bai Y; Yang C Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654 [TBL] [Abstract][Full Text] [Related]
2. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429 [TBL] [Abstract][Full Text] [Related]
3. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal. Zhang J; Zhang DL; Jiao XL; Dong Q Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232 [TBL] [Abstract][Full Text] [Related]
4. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528 [TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. Ma X; Yang Y; Wang Y; An G; Lv G Cancer Lett; 2010 Dec; 299(2):171-81. PubMed ID: 20855150 [TBL] [Abstract][Full Text] [Related]
6. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13. Wang L; Wang X; Liang Y; Diao X; Chen Q Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804 [TBL] [Abstract][Full Text] [Related]
7. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis. Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4. Xiao Y; Zhao Q; Du B; Chen HY; Zhou DZ Cancer Invest; 2018 Jan; 36(1):1-9. PubMed ID: 29303365 [TBL] [Abstract][Full Text] [Related]
9. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal. Ren XF; Zhao H; Gong XC; Wang LN; Ma JF Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929 [TBL] [Abstract][Full Text] [Related]
10. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway. Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486 [TBL] [Abstract][Full Text] [Related]
12. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness. Matsuura I; Lai CY; Chiang KN Biochem J; 2010 Feb; 426(3):327-35. PubMed ID: 20070253 [TBL] [Abstract][Full Text] [Related]
14. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538 [TBL] [Abstract][Full Text] [Related]
15. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells. Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932 [TBL] [Abstract][Full Text] [Related]
16. Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma. Fujiwara M; Kashima TG; Kunita A; Kii I; Komura D; Grigoriadis AE; Kudo A; Aburatani H; Fukayama M Tumour Biol; 2011 Jun; 32(3):611-22. PubMed ID: 21360024 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma. Huang H; Zheng HY; Liu ZL; Zhang L Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic significance of S100A4 expression in osteosarcoma. Cao CM; Yang FX; Wang PL; Yang QX; Sun XR Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo. Zhang K; Yu M; Hao F; Dong A; Chen D Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway. Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]